Premium Information is available for this item - Upgrade for $1 a day
6505-01-374-5866
Ondansetron Hydrochloride Tablets
6505013745866 013745866 ZOFRAN TABLETS ZOFRAN NDC00173-0446-00
INC: 49831 Ondansetron Hydrochloride Tablets
Managed by United States
NSN Created on 26 Apr 1993
Data Last Changed
November 2023
November 2023
NATO Update Count
8
8
NATO Data Quality
Marketplace 6505-01-374-5866
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-374-5866 5+ Documents (More...)
ZOFRAN TABLETS ZOFRAN NDC00173-0446-00 Managed by United States NSN Created on 26 Apr 1993 Data Last
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-5868 Ondansetron Hydrochloride Tablets 013745868 ZOFRAN
Ondansetron Hydrochloride Tablets 013745866 www.nsnlookup.com /fsg-65/fsc-6505/fr ZOFRAN Ondansetron
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-5868 Ondansetron Hydrochloride Tablets 013745868 ZOFRAN
Ondansetron Hydrochloride Tablets 013745866 www.nsnlookup.com /fsg-65/fsc-6505/fr ZOFRAN Ondansetron
-006-2305 https//www.nsnlookup.com https 0137501296505-01-375-0129 6505-27-008-0244 000-8445 6505-01-374-5866
6505-14-506-1920 6505-21-912-6381 6505-27-006-2305 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-5866
Ondansetron Hydrochloride Tablets 013745866 fsg-65/fsc-6505/us 6505-01-374-5866 Ondansetron https
6505-14-506-1920 6505-21-912-6381 6505-27-006-2305 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-5866
Ondansetron Hydrochloride Tablets 013745866 fsg-65/fsc-6505/us 6505-01-374-5866 Ondansetron https
ZOFRAN TABLETS NDC00173-0447-04 Managed by United States NSN Created on 26 Apr 1993 Data Last Changed
Ondansetron Hydrochloride Tablets 013745866 Upgrade your Account Upgrade 6505-01-374-5866Ondansetron
Hydrochloride Tablets6505013745866 013745866 ZOFRAN ZOFRAN https Tablets 013745866 Ondansetron Hydrochloride
Ondansetron Hydrochloride Tablets 013745866 Upgrade your Account Upgrade 6505-01-374-5866Ondansetron
Hydrochloride Tablets6505013745866 013745866 ZOFRAN ZOFRAN https Tablets 013745866 Ondansetron Hydrochloride
Ondansetron Hydrochloride Tablets 013745866 your Account Upgrade 6505-01-374-5866Ondansetron https
www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-506-1920 Ondansetron Hydrochloride Tablets 145061920 ZOFRAN
-506-1920 Ondansetron Hydrochloride Tablets 145061920 Tablets6505219126381 219126381 DIN 01925989 ZOFRAN
www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-506-1920 Ondansetron Hydrochloride Tablets 145061920 ZOFRAN
-506-1920 Ondansetron Hydrochloride Tablets 145061920 Tablets6505219126381 219126381 DIN 01925989 ZOFRAN
enable JavaScript in your web browser . 6505-99-899-7281Glibenclamide Table6505998997281 998997281 ZOFRAN
ZOFRAN TABLETS Last NSN Created on 26 Apr 1993 Data Last NSN Created on 26 Apr 1993 Data Last 5 RNVC
1 DAC 4 ZOFRAN TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN
ZOFRAN TABLETS Last NSN Created on 26 Apr 1993 Data Last NSN Created on 26 Apr 1993 Data Last 5 RNVC
1 DAC 4 ZOFRAN TABLETS https//www.nsnlookup.com /fsg-65/ Secondary Reference RNCC 5 RNVC 1 DAC 4 ZOFRAN
Restrictions 6505-01-374-5866
6505-01-374-5866 is a Ondansetron Hydrochloride Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). This item does not contain a precious metal.
Approved Sources 6505-01-374-5866
- Part Number
- Manufacturer
- Status
- NDC00173-0446-00
- Manufacturer
- 34006 - Glaxo Wellcome Inc (Active)
- Primary Buy
- Primary Buy
- ZOFRAN TABLETS
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- ZOFRAN
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Management Data 6505-01-374-5866
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 2003
- Department of the Army (DA)
- BT
- Subscribe
- 1
- BT
- Dec 2002
- Department of the Navy (DN)
- BT
- Subscribe
- 1
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Department of the Navy (DN)
- N
- K
- U/I Contains 30 Tt
- 00000000030TT
- K
- Department of the Navy (DN)
- N
- V
- Discontinued Without Replacement
- V
Army
- Materiel Category and Inventory Manager:
- C
- Medical/Dental Materiel
- Appropriation and Budget Activity:
- 2
- Stock Fund Secondary Items
- Management Inventory Segment:
- 2
- Non-Repairable Items(Exclusive of Insurance and Provisioning Items)
This code will be used to identify items, which are not reparable.
- Weapons System / End Item / Homogeneous Group:
- 01
- DLA/GSA Material
Type 1 (Non-Extendable) Potency Dated Item
- Accounting Requirements:
- X
- Expendable item.An item of Army property coded with an ARC of X in the AMDF. Expendable items require no formal accountability after issue from a stock record account.Commercial and fabricated items similar to items coded X in the AMDF are considered expendable items.
Navy
- Cognizance:
- 9L
Similar Supply Items to 6505-01-374-5866
